Virtu Financial LLC reduced its position in UnitedHealth Group Inc (NYSE:UNH) by 74.3% in the 1st quarter, Holdings Channel reports. The firm owned 4,596 shares of the healthcare conglomerate’s stock after selling 13,297 shares during the period. Virtu Financial LLC’s holdings in UnitedHealth Group were worth $1,136,000 as of its most recent filing with the SEC.
A number of other large investors have also recently modified their holdings of UNH. Vanguard Group Inc grew its stake in UnitedHealth Group by 1.6% during the 3rd quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock valued at $18,447,892,000 after purchasing an additional 1,073,505 shares in the last quarter. BKD Wealth Advisors LLC lifted its holdings in UnitedHealth Group by 18.0% during the 4th quarter. BKD Wealth Advisors LLC now owns 6,064 shares of the healthcare conglomerate’s stock worth $1,511,000 after buying an additional 926 shares during the last quarter. Cornerstone Advisors Inc. lifted its holdings in UnitedHealth Group by 7.9% during the 4th quarter. Cornerstone Advisors Inc. now owns 1,646 shares of the healthcare conglomerate’s stock worth $410,000 after buying an additional 121 shares during the last quarter. Hotaling Investment Management LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $1,804,000. Finally, Pratt Collard Advisory Partners LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $207,000. Institutional investors and hedge funds own 87.29% of the company’s stock.
Shares of UNH stock traded down $0.03 during mid-day trading on Wednesday, hitting $249.91. 45,441 shares of the stock traded hands, compared to its average volume of 5,249,007. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The stock has a market cap of $229.39 billion, a PE ratio of 19.41, a price-to-earnings-growth ratio of 1.29 and a beta of 0.74. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 0.73.
UNH has been the topic of a number of research analyst reports. Credit Suisse Group reaffirmed a “buy” rating and set a $310.00 target price on shares of UnitedHealth Group in a report on Friday, February 8th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, March 19th. Raymond James reduced their target price on UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating on the stock in a report on Wednesday, April 17th. Morgan Stanley cut their price target on UnitedHealth Group from $315.00 to $285.00 and set an “overweight” rating on the stock in a report on Wednesday, April 17th. Finally, ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 27th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $290.84.
In related news, CEO David S. Wichmann bought 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 3rd. The shares were acquired at an average cost of $231.79 per share, for a total transaction of $4,635,800.00. Following the acquisition, the chief executive officer now directly owns 904,367 shares of the company’s stock, valued at approximately $209,623,226.93. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total value of $1,225,050.00. Following the completion of the transaction, the director now owns 182,372 shares in the company, valued at $44,682,963.72. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,930 shares of company stock worth $6,746,683. 0.87% of the stock is owned by insiders.
WARNING: This piece was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/05/22/unitedhealth-group-inc-unh-position-cut-by-virtu-financial-llc.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What is the market perform rating?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.